Your session is about to expire
← Back to Search
Dermabond for Ascites-related Fluid Leaks
Study Summary
This trial found that 2-Octyl cyanoacrylate (2-OCA) is an effective treatment for fluid leaks following paracentesis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a procedure called paracentesis, but it was not done using the 18 gauge Safe-T-Centesis kit.
- Group 1: Glue Group (GG)
- Group 2: No Glue Group (NG)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible for me to become involved in this clinical trial?
"This clinical trial is accepting 134 patients aged between 18 and 100 who suffer from ascites. The study necessitates that the participants be admitted to Methodist Dallas Medical Centre, where their paracentesis will be done in-house by a specialist bedside procedure team."
Does this experiment still welcome participants?
"According to clinicaltrials.gov, the registration period for this trial has closed; it was initially posted on January 13th 2022 and last updated October 21st of the same year. Despite this, 35 other medical trials are presently recruiting patients."
Is the age criterion for this clinical trial restricted to individuals younger than 35 years old?
"To qualify for participation in this clinical trial, prospective subjects must be between 18 and 100 years old. Furthermore, there is one study specifically dedicated to those under the age of 18 while 33 studies are available for seniors above 65."
Share this study with friends
Copy Link
Messenger